Corcept Therapeutics Incorporated (NASDAQ:CORT) is among the most promising growth stocks according to analysts. According to an Investing.com report, William Guyer, Chief Development Officer at Corcept Therapeutics Incorporated (NASDAQ:CORT), sold 20,000 shares of common stock valued at $703,656…
Continue reading...